to view your mail
Yahoo Finance Plus
U.S. markets closed
ADMA Biologics, Inc. (ADMA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 4:00PM EDT
2,943 reactions on $ADMA conversation
Sign in to post a message.
"With consideration to the significant asset valuation arbitrage as well as the additional value yet to be realized for our anticipated future cash flows, we are actively evaluating all strategic and financial alternatives to maximize stockholder value and minimize equity dilution." I think they think that the company is worth 3-4 times current market cap.
Adma soared instantly to 2.63 on news in late April that the FDA approved increased production. At 1.67 today, that represents a 57.5% increase on current share price. Imagine when additional positive news starts rolling in- potential acquisition, new blood plasma centers opening, etc. This is a no brainer. The CEO owns 1.8m shares. He has serious skin in the game. You know he is going to do everything in his power to see share prices increase, including positive “surprises” that will generate lots of interest and cause the share price to shoot up. I am in now when the getting is good. Wait till it shots up again and you lose the early gains. Remember, this was at 2.95 in Feb 2021. It will head north again soon. If you have patience, and hold from current pricing till end of year, I predict 3.5 to 4 per share, meaning at least a 100% gain. Long and strong!
Ive been on the market for 20 years+ and I've never seen anything quite like we see nowadays: stock exploses on no news, web forums at war to pump some random stocks, massive shortage on good news... Maybe I'm getting old, but I feel like I don't understand the markets anymore. Kind of scary I should say.
kiSTEVEN M STAMPLER
Big day for company as we have earnings again AH. What are we going to get?? They have consistently increased their revenues quarter by quarter but their gross margin and net income have not caught up. This weakness has fueled a large short selling as evidenced by the 220 million shares traded day we had recently. I will be watching the numbers closely for any evidence of improvement in these key areas. The company has only recently addressed these issues but have maintained that the improvements will begin in earnest during the second half of this year and ramping up after that. I have been increasing my position at these low price levels and selling covered calls as well which is a great strategy in a stock that has been going down in price. Good luck to everyone today and lets hope for some better numbers.....
GOOD OR BAD RESULTS, NORMALLY SEEN THEY WILL BE GOOD. AND DON'T FORGET THIS, PRODUCTION FROM 4400 GOES HIGHER WITH FDA AUTHORIZATION.
Notably, ADMA’s 4,400-liter IVIG plasma pool scale for BIVIGAM will expand the total processing capacity from 400,000 liters to an expected 600,000 liters.
Great call. My takeaway: a buyout announcement will be coming soon. Consolidation in the space is a good thing. Shareholders will be rewarded nicely.
The short interest is up to 14.05M....11.61% of the o/s....the trend jumped up from the last timeframe, unfortunately...glta
IVIG saves lives. While ADMA Management highlighted the YOY 57% revenue increase and current asset value of $235 M during the call, the uniqueness of their product and growing plasma demand even after the pandemic, did not get enough emphasis. This moat is what investors prefer to hear IMO. Many stocks in various other industries are reporting impressive net gains with little, even negative effect on their stock prices. My friend’s parents recently tested positive and IVIG helped make a difference between life or death.
This company is a rising star and it's at such a low price! As earnings increase our share value has no where to go but UP UP UP!
Beat earnings buy buy buy now
Did Grossman just say they were hoping to set the company up to to be sold? Sounds like the same thing he said in the cc....glta
***only 2 analysts....delivering nothing to shareholders today....but there is always tomorrow!
what a joke. earnings beat. market up... and ADMA continues to seek new lows daily
“A number of hedge funds have recently bought and sold shares of ADMA. Morgan Stanley increased its stake in ADMA Biologics by 21.8% in the 3rd quarter. Morgan Stanley now owns 249,212 shares of the biotechnology company’s stock worth $596,000 after buying an additional 44,683 shares during the period. Schonfeld Strategic Advisors LLC increased its position in ADMA Biologics by 24.7% during the 3rd quarter. Schonfeld Strategic Advisors LLC now owns 731,723 shares of the biotechnology company’s stock valued at $1,748,000 after purchasing an additional 144,806 shares during the period. Jane Street Group LLC increased its position in ADMA Biologics by 92.8% during the 3rd quarter. Jane Street Group LLC now owns 20,056 shares of the biotechnology company’s stock valued at $48,000 after purchasing an additional 9,656 shares during the period. Virtu Financial LLC purchased a new position in ADMA Biologics during the 3rd quarter valued at about $224,000. Finally, Meridian Wealth Management LLC increased its position in ADMA Biologics by 66.7% during the 4th quarter. Meridian Wealth Management LLC now owns 100,000 shares of the biotechnology company’s stock valued at $195,000 after purchasing an additional 40,000 shares during the period. 48.90% of the stock is currently owned by institutional investors.”
Just remember this statement made in the press release APRIL 28, 2021. Good luck to all Longs
“The FDA approval of the 4,400-liter IVIG plasma pool production scale process is a transformative milestone for the ADMA organization and will allow the Company to produce significantly more IVIG for the U.S. market and for patients living with immune deficiencies,” said Adam Grossman, President and Chief Executive Officer of ADMA. “The expanded plasma pool production scale allows us to confidently commit to generating peak revenues in excess of $300 million and this approval solidifies the pathway to meaningful gross margin expansion beginning potentially in the second half of 2021 and accelerating throughout 2022. In addition to the increase in ADMA’s multi-year financial guidance, the Company is reiterating its expectation for quarter-over-quarter revenue growth throughout 2021 and beyond."
Do not panic sell. This is a classic example of market manipulation. The fact is that insider trading always goes on even though some disagree. This is typical of most stocks going into earnings. If the ER is good or OK the stocks prices always go down in an effort to get people to panic sell so the MM can buy your cheap shares. If the ER is bad then they run the prices up in order to make a profit before it tanks after the ER. The key to stock trading is to be patient and not fall for these tricks. The fact is that ADMA has important medical products and the demand for medical products is never going away.
I BELIEVED IN PROFIT IN THE FIRST QUARTER AND HAVE BEEN OUT OF IT, HAD ALREADY PURCHASED 2,000, ANOTHER 3,000 THIS NIGHT BEFORE CLOSING 2 HOURS AT NIGHT, HOPE MORE PURCHASES WILL FOLLOW, THE 2ND AND 3RD QUARTERS WILL BE MUCH BETTER YEARS AND NEXT THE DOUBLE. A LOT OF SUCCESS ALL FOR THOSE WHO BELIEVED IN THE SHARE.
Some are buying and some are selling: Who is buying/keeping their position and why?
5/10/2021 Principal Financial Group Inc. 360,511 $0.63M 0.0% +7.4% 0.297%
5/10/2021 GSA Capital Partners LLP 549,624 $0.97M 0.2% +68.1% 0.453%
5/7/2021 BlackRock Inc. 5,753,820 $10.13M 0.0% +6.1% 4.744%
5/5/2021 Los Angeles Capital Management LLC 39,265 $69K 0.0% -46.5% 0.032%
5/4/2021 Commonwealth Equity Services LLC 50,354 $88K 0.0% N/A 0.042%
ADMA is being very punished by Wall Street, all the conditions are in place, FDA approved and now a good earnings report, what more is required, I have 14 months of investment in this company and I have not been able to see profits, enough patience, with this investment would have tripled my earnings in this time, I am definitely out of ADMA but without losing. Today it must have risen at least 15%.
When will ADMA be approved for emergency use funding? I know they initially got rejected but resubmitted a new application.
Folks - its very simple it's called the DILLUTION OVERHANG
When you seek shareholder approval to increase the authorized shares from 150 million to 300 million this is how the stock will behave via the potential for 100% dilution . Lets say they are lucky and issue these at $2 that's an additional $300 million of cash proceeds . For what. Why so much,. Are you opening 100 centers. They scared the market. Management doesn't get it. Not street savvy.
$1400 Stimulus May Be on the Way — This Time from Your State
Jeffrey Gundlach on where he sees opportunities in the market
Yahoo Finance Video
Tesla’s Musk Renews Critique of Bitcoin, Talks Up Dogecoin
Advertise with us
© 2021 Verizon Media. All rights reserved.
About Our Ads
Discover new investment ideas by accessing unbiased, in-depth investment research